Stocks
PepGen Inc.PEPG
NASDAQHealthcareBiotechnology$2.52
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing peptide-based therapies for rare diseases and oncology. Its lead programs target well-validated molecular pathways, and the company has attracted investor interest due to its pipeline progress and potential for strategic partnerships.
52W Range: $1.31-$7.80
Congressional Interest in PepGen Inc. (PEPG)
No congressional trades have been disclosed for PepGen Inc. (PEPG) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading PEPG?
No congressional trades found for this stock.